‌

US Patent 10646456 Methods of administering amantadine

Overview Structured Data Issues Contributors

Is a

Date Filed

November 13, 2018

Date of Patent

May 12, 2020

Patent Application Number

16188770

Patent Citations

US Patent 10154971 Methods of administering amantadine

Patent Citations Received

US Patent 11505593 Anti-VEGF protein compositions and methods for producing the same

US Patent 11535663 Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

US Patent 12103960 VEGF traps and mini-traps and methods for treating ocular disorders and cancer

0

US Patent 11459374 Anti-VEGF protein compositions and methods for producing the same

US Patent 11472861 Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

US Patent 11485770 Anti-VEGF protein compositions and methods for producing the same

US Patent 11505594 Anti-VEGF protein compositions and methods for producing the same

US Patent 12077570 Anti-VEGF protein compositions and methods for producing the same

0

US Patent 11459373 Anti-VEGF protein compositions and methods for producing the same

US Patent 11542317 Anti-VEGF protein compositions and methods for producing the same

•••

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Primary Examiner

Find more entities like US Patent 10646456 Methods of administering amantadine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.